乌帕替尼

Description

Upadacitinib · CAS 1310726-60-3 · C17H19F3N6O. UNII 4RA0KN46E0. Boiling Point: 189; Melting Point: 16-19.

Identification

CAS Registry Number	1310726-60-3
PubChem CID	58557659
Molecular formula	C17H19F3N6O
IUPAC name	(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
UNII (FDA)	4RA0KN46E0

Computed Descriptors

Molecular Weight	380.4
XLogP3	2.7
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	3
Exact Mass	380.15724374
Monoisotopic Mass	380.15724374
Topological Polar Surface Area	78.3
Heavy Atom Count	27
Formal Charge	0

Physical & Chemical Properties

Boiling Point	189
Melting Point	16-19

Documented Uses

• Upadacitinib is a new FDA-approved second-line agent for treating moderate to severe active rheumatoid arthritis (RA) in patients who have not shown an adequate response or intolerance to the first-line agent, methotrexate. This agent is a second-generation selective Janus kinase (JAK) inhibitor targeting the JAK1 enzyme. Upadacitinib received FDA approval on August 16, 2019, based on positive and promising results from its multinational phase III trials in subjects with moderate to severe rheumatoid arthritis.
• Upadacitinib is an oral selective inhibitor of Janus associated kinase 1 (JAK-1) that is used in the therapy of moderate-to-severe rheumatoid arthritis. Upadacitinib has been associated with a low rate of serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent acute liver injury although it may pose a risk for reactivation of hepatitis B in susceptible patients.
• Breast Feeding; Lactation; Milk, Human; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors; Janus Kinase Inhibitors; JAK Inhibitors
• Avoid grapefruit products. Upadacitinib exposure is increased when a strong CYP3A4 inhibitor such as grapefruit is used, which may increase the risk for drug-related adverse events.
• Avoid St. John's Wort. This herb induces CYP3A metabolism and may reduce serum levels of upadacitinib.
• Take with or without food. Food does not significantly affect drug concentrations.

Synonyms

Upadacitinib; 1310726-60-3; ABT-494; Upadacitinib anhydrous; 4RA0KN46E0; DTXSID901027919; upadacitinibum; RefChem:57163; L04AA44; DTXCID401513480; Rinvoq; ABT 494; EX-A1628; DB15091; ABBV-599 COMPONENT UPADACITINIB; UNII-4RA0KN46E0

Frequently Asked Questions

What are the CAS number and molecular formula of Upadacitinib?

CAS 1310726-60-3; molecular formula C17H19F3N6O; molecular weight — g/mol.

What other names is Upadacitinib known by?

Upadacitinib, 1310726-60-3, ABT-494, Upadacitinib anhydrous, 4RA0KN46E0, DTXSID901027919.

What are the key physical properties of Upadacitinib?

Boiling Point: 189; Melting Point: 16-19.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.